Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03022578
What this trial is testing

Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

Who this might be right for
IDH Family WildtypeRecurrent Anaplastic AstrocytomaRecurrent Glioblastoma
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Looking for participantsNCT07263438
What this trial is testing

Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial

Who this might be right for
GlioblastomaRecurrence Tumor
Centre Hospitalier Universitaire Vaudois 59
Early research (Phase 1)Study completedNCT00025558
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer

Who this might be right for
Brain and Central Nervous System Tumors
NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT03744026
What this trial is testing

Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9

Who this might be right for
Glioblastoma, Adult
CarThera 38
Post-approval studies (Phase 4)WithdrawnNCT05900908
What this trial is testing

Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy

Who this might be right for
Glioblastoma
GT Medical Technologies, Inc.
Testing effectiveness (Phase 2)Study completedNCT02794883
What this trial is testing

Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaRecurrent Glioblastoma
Northwestern University 36
Early research (Phase 1)UnknownNCT00360854
What this trial is testing

Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Cancer and Leukaemia Group 48
Testing effectiveness (Phase 2)Study completedNCT00085566
What this trial is testing

Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

Who this might be right for
Brain and Central Nervous System TumorsProstate Cancer
Memorial Sloan Kettering Cancer Center 61
Testing effectiveness (Phase 2)Study completedNCT04013672
What this trial is testing

Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence

Who this might be right for
Recurrent Glioblastoma
David Peereboom 41
Early research (Phase 1)Looking for participantsNCT05577091
What this trial is testing

Tris-CAR-T Cell Therapy for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Beijing Tiantan Hospital 10
Early research (Phase 1)Active Not RecruitingNCT02062827
What this trial is testing

Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma

Who this might be right for
Recurrent Glioblastoma MultiformeProgressive Glioblastoma MultiformeAnaplastic Astrocytoma or Gliosarcoma
University of Alabama at Birmingham 29
Early research (Phase 1)Active Not RecruitingNCT05222802
What this trial is testing

Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)

Who this might be right for
Glioblastoma Multiforme
Katmai Pharmaceuticals Inc. 52
Early research (Phase 1)Ended earlyNCT03283631
What this trial is testing

Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM

Who this might be right for
Recurrent GlioblastomaRecurrent Gliosarcoma
Gary Archer Ph.D. 2
Early research (Phase 1)Ended earlyNCT00045721
What this trial is testing

Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 3
Not applicableStudy completedNCT01836536
What this trial is testing

Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients

Who this might be right for
GlioblastomaGlioma
Center Eugene Marquis 30
Testing effectiveness (Phase 2)Study completedNCT00612430
What this trial is testing

Ph II Bevacizumab + Etoposide for Pts w Recurrent MG

Who this might be right for
GlioblastomaGliosarcoma
Duke University 59
Testing effectiveness (Phase 2)Study completedNCT00005081
What this trial is testing

Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Testing effectiveness (Phase 2)Study completedNCT00329719
What this trial is testing

Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Adult GlioblastomaAdult GliosarcomaRecurrent Adult Brain Neoplasm
National Cancer Institute (NCI) 115
Early research (Phase 1)Active Not RecruitingNCT03423628
What this trial is testing

Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Who this might be right for
Recurrent Glioblastoma MultiformePrimary Glioblastoma MultiformeBrain Neoplasms, Malignant+1 more
AstraZeneca 159
Early research (Phase 1)Active Not RecruitingNCT03961971
What this trial is testing

Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM

Who this might be right for
Glioblastoma Multiforme
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 16
Next Page